In the International Journal of Neuroscience, 2012;122:354-7, for the article “A 17-year experience of abobotulinumtoxinA in cervical dystonia,” the authors have noticed the following errors since publication.
The corresponding author's email address should have read as follows:
Address correspondence to Francisco Vivancos-Matellano, M.D., Medico Adjunto Servicio Neurologia La Paz, Jefe Unidad Trastornos Del Movimiento, Paseo de la Castellana, 261 28046 Madrid, Spain. E-mail: [email protected]
In addition, there was an error in the declaration of interests, which read “Declaration of interest: Francisco Vivancos-Matellano has neither a personal nor a professional relationship with IPSEN regarding the study ‘12 years experience in cervical dystonia BoNT-A treatment.’ ”
This should have read 17 years experience as follows:
Declaration of interest: Francisco Vivancos-Matellano has neither a personal nor a professional relationship with IPSEN regarding the study “17 years experience in cervical dystonia BoNT-A treatment.”
The first sentance of the Introduction section should have had the last incorrect phase “or 0.390%” removed, to read:
“Cervical dystonia (CD) is the most common form of focal dystonia, with an estimated prevalence of 9 per 100.000 [1].”
The affiliations for Drs Vivancos-Matellano and Ybot-Gorrin should have included “Movement Disorder Unit”:
Neurology Department, Movement Disorder Unit, La Paz University Hospital, Paseo Castellana 261, Madrid, Spain
The authors and publishers apologize for these errors.